Voltar
Artigo Revisado por pares
BIBTEX RIS

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

2006; Lippincott Williams & Wilkins; Volume: 25; Issue: 1 Linguagem: Inglês

10.1200/jco.2006.09.2775

ISSN

1527-7755

Autores

Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz, Karen L. Hagerty, D. Craig Allred, Richard J. Côté, Mitch Dowsett, Patrick L. Fitzgibbons, Wedad Hanna, Amy S. Langer, Lisa M. McShane, Soonmyung Paik, Mark D. Pegram, Edith A. Perez, Michael F. Press, Anthony Rhodes, Catharine M. Sturgeon, Sheila E. Taube, Raymond Tubbs, Gail H. Vance, Marc J. van de Vijver, Thomas M. Wheeler, Daniel F. Hayes,

Tópico(s)

Advanced Biosensing Techniques and Applications

Resumo

To develop a guideline to improve the accuracy of human epidermal growth factor receptor 2 (HER2) testing in invasive breast cancer and its utility as a predictive marker.

Referência(s)